{"title":"Molecular Mechanism of TRIM16 Regulating Osteogenic Differentiation of Periodontal Ligament Stem Cells Under Inflammatory Microenvironment","authors":"Xudong Ma","doi":"10.1002/cbin.70192","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>This study explores the mechanism of TRIM16 on osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) in an inflammatory microenvironment. hPDLSCs were cultured and identified by flow cytometry and osteogenesis/adipogenesis induction. hPDLSCs were maintained with <i>P. gingivalis</i> LPS and induced by osteogenic differentiation. TRIM16, HOXA10, and KLF5 expression was tested via RT-qPCR and Western blot. After overexpression of TRIM16, TNF-α, IL-6, and IL-1β levels were examined via ELISA. Osteogenic differentiation of hPDLSCs was validated by Alizarin red staining, ALP staining, and Western blot. The binding of TRIM16 to HOXA10 was detected by Co-IP, and the ubiquitinated HOXA10-containing complexes were measured. Dual luciferase assay and ChIP analyzed the enrichment of HOXA10 on the KLF5 promoter. LPS treatment reduces TRIM16 and KLF5 expression, while elevating HOXA10 protein level. Overexpression of TRIM16 alleviates inflammation in LPS-induced hPDLSCs and enhances osteogenic differentiation. Mechanistically, TRIM16 inhibits HOXA10 protein level via ubiquitination, thereby abating the enrichment of HOXA10 on the KLF5 promoter and promoting the expression of KLF5. In conclusion, TRIM16 facilitates osteogenic differentiation of hPDLSCs in an inflammatory microenvironment via HOXA10/KLF5 axis.</p>\n </div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 8","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology International","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbin.70192","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This study explores the mechanism of TRIM16 on osteogenic differentiation of human periodontal ligament stem cells (hPDLSCs) in an inflammatory microenvironment. hPDLSCs were cultured and identified by flow cytometry and osteogenesis/adipogenesis induction. hPDLSCs were maintained with P. gingivalis LPS and induced by osteogenic differentiation. TRIM16, HOXA10, and KLF5 expression was tested via RT-qPCR and Western blot. After overexpression of TRIM16, TNF-α, IL-6, and IL-1β levels were examined via ELISA. Osteogenic differentiation of hPDLSCs was validated by Alizarin red staining, ALP staining, and Western blot. The binding of TRIM16 to HOXA10 was detected by Co-IP, and the ubiquitinated HOXA10-containing complexes were measured. Dual luciferase assay and ChIP analyzed the enrichment of HOXA10 on the KLF5 promoter. LPS treatment reduces TRIM16 and KLF5 expression, while elevating HOXA10 protein level. Overexpression of TRIM16 alleviates inflammation in LPS-induced hPDLSCs and enhances osteogenic differentiation. Mechanistically, TRIM16 inhibits HOXA10 protein level via ubiquitination, thereby abating the enrichment of HOXA10 on the KLF5 promoter and promoting the expression of KLF5. In conclusion, TRIM16 facilitates osteogenic differentiation of hPDLSCs in an inflammatory microenvironment via HOXA10/KLF5 axis.
期刊介绍:
Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.
These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.